These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12359990)

  • 21. The individual RDH index: a novel vector index for statistical assessment of antihypertensive treatment reduction, duration, and homogeneity.
    Aboy M; Fernández JR; McNames J; Hermida RC
    Blood Press Monit; 2006 Apr; 11(2):69-78. PubMed ID: 16534408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of prescribing, dispensing, and patient use pattern of antihypertensive drugs for patients attending outpatient department of Hiwot Fana Specialized University Hospital, Harar, Eastern Ethiopia.
    Shukrala F; Gabriel T
    Drug Des Devel Ther; 2015; 9():519-23. PubMed ID: 25632220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypertension Treatment ACCORDing to SPRINT.
    Campos K; Sheth S; Coulter SA
    Tex Heart Inst J; 2016 Aug; 43(4):324-7. PubMed ID: 27547143
    [No Abstract]   [Full Text] [Related]  

  • 24. Treating blood pressure between 140/90 and 160/95 mmHg: no proven benefit.
    Prescrire Int; 2014 Apr; 23(148):106. PubMed ID: 24860904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Moxonidine in the treatment of overweight and obese patients with the metabolic syndrome: a postmarketing surveillance study.
    Sharma AM; Wagner T; Marsalek P
    J Hum Hypertens; 2004 Sep; 18(9):669-75. PubMed ID: 15269705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global Impact of 2017 American College of Cardiology/American Heart Association Hypertension Guidelines: A Perspective From China.
    Wang JG; Liu L
    Circulation; 2018 Feb; 137(6):546-548. PubMed ID: 29431657
    [No Abstract]   [Full Text] [Related]  

  • 27. Multiple Cardiovascular Risk Factors Indicate Cardiovascular Disease in Stage 1 Hypertension.
    DeMarzo AP
    High Blood Press Cardiovasc Prev; 2019 Apr; 26(2):135-137. PubMed ID: 30719630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of antihypertensive agents in people at high risk of cardiovascular disease and diabetes: a view through smoke and mirrors.
    McInnes GT
    J Hum Hypertens; 2011 Jun; 25(6):343-5. PubMed ID: 21390054
    [No Abstract]   [Full Text] [Related]  

  • 29. Telmisartan provides superior BP reduction from morning to morning compared to other leading ARBs.
    Cardiovasc J S Afr; 2006; 17(4):210. PubMed ID: 17001428
    [No Abstract]   [Full Text] [Related]  

  • 30. Resistant hypertension: bad and getting worse.
    Ahmed MI; Calhoun DA
    Hypertension; 2011 Jun; 57(6):1045-6. PubMed ID: 21502566
    [No Abstract]   [Full Text] [Related]  

  • 31. Upward hypertension trends: changes in blood pressure or in antihypertensive treatment?
    Chiolero A; Paccaud F; Bovet P
    Hypertension; 2009 Mar; 53(3):e22; author reply e23. PubMed ID: 19171790
    [No Abstract]   [Full Text] [Related]  

  • 32. [Arterial hypertension: an update].
    Verdecchia P; Angeli F; Mazzotta G; Gentile G; Reboldi G
    G Ital Cardiol (Rome); 2010 May; 11(5 Suppl 3):74S-77S. PubMed ID: 20879486
    [No Abstract]   [Full Text] [Related]  

  • 33. Global Impact of 2017 American Heart Association/American College of Cardiology Hypertension Guidelines: A Perspective From India.
    Wander GS; Ram CVS
    Circulation; 2018 Feb; 137(6):549-550. PubMed ID: 29431658
    [No Abstract]   [Full Text] [Related]  

  • 34. Icarus, Blood Pressure, and the Dangers of Flying Too Close to the Sun.
    Skolnik N
    Circulation; 2018 Mar; 137(11):1097-1099. PubMed ID: 29530889
    [No Abstract]   [Full Text] [Related]  

  • 35. Global Impact of 2017 American Heart Association/American College of Cardiology Hypertension Guidelines: A Perspective From Japan.
    Kario K
    Circulation; 2018 Feb; 137(6):543-545. PubMed ID: 29431656
    [No Abstract]   [Full Text] [Related]  

  • 36. Impact of antihypertensive combination and monotreatments on blood pressure variability: assessment by old and new indices. Data from a large ambulatory blood pressure monitoring database.
    Parati G; Dolan E; Ley L; Schumacher H
    J Hypertens; 2014 Jun; 32(6):1326-33. PubMed ID: 24759124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of hypertension: pharmacotherapy.
    Campbell N; Chockalingam A
    Indian Heart J; 2005; 57(6):644-7. PubMed ID: 16521630
    [No Abstract]   [Full Text] [Related]  

  • 38. [Necessity of achievement of target arterial pressure: the use of fixed combination antihypertensive preparations as starting therapy].
    Ostroumova OD; Zhukova OV; Golovina OV; Khvorostianaia IV
    Kardiologiia; 2009; 49(4):67-71. PubMed ID: 19463123
    [No Abstract]   [Full Text] [Related]  

  • 39. Risks versus benefits of withdrawing antihypertensive therapy.
    Schobel HP; Schmieder RE; Messerli FH
    Drug Saf; 1992; 7(6):395-403. PubMed ID: 1418696
    [No Abstract]   [Full Text] [Related]  

  • 40. Hypertension Across the Atlantic: A Sprint or a Marathon?
    Volpe M; Citoni B; Coluccia R; Battistoni A; Tocci G
    High Blood Press Cardiovasc Prev; 2017 Jun; 24(2):99-102. PubMed ID: 28451910
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.